These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 15182961

  • 1. Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
    Muhlack S, Woitalla D, Welnic J, Twiehaus S, Przuntek H, Müller T.
    Neurosci Lett; 2004 Jun 17; 363(3):284-7. PubMed ID: 15182961
    [Abstract] [Full Text] [Related]

  • 2. Homocysteine levels after acute levodopa intake in patients with Parkinson's disease.
    Müller T, Kuhn W.
    Mov Disord; 2009 Jul 15; 24(9):1339-43. PubMed ID: 19425084
    [Abstract] [Full Text] [Related]

  • 3. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov 15; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.
    Contin M, Martinelli P, Mochi M, Riva R, Albani F, Baruzzi A.
    Mov Disord; 2005 Jun 15; 20(6):734-9. PubMed ID: 15747357
    [Abstract] [Full Text] [Related]

  • 7. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA, Gachoud JP.
    Praxis (Bern 1994); 1995 Oct 24; 84(43):1235-8. PubMed ID: 7481341
    [Abstract] [Full Text] [Related]

  • 8. Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease.
    Priano L, Albani G, Brioschi A, Calderoni S, Lopiano L, Rizzone M, Cavalli R, Gasco MR, Scaglione F, Fraschini F, Bergamasco B, Mauro A.
    Mov Disord; 2004 Aug 24; 19(8):937-42. PubMed ID: 15300660
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease. Parkinson Study Group.
    Clin Neuropharmacol; 1999 Aug 24; 22(4):220-5. PubMed ID: 10442252
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.
    Kulisevsky J, Pascual-Sedano B, Barbanoj M, Gironell A, Pagonabarraga J, García-Sánchez C.
    Mov Disord; 2007 Jan 24; 22(1):62-7. PubMed ID: 17115388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Levodopa availability improves with progression of Parkinson's disease.
    Woitalla D, Goetze O, Kim JI, Nikodem AB, Schmidt WE, Przuntek H, Müller T.
    J Neurol; 2006 Sep 24; 253(9):1221-6. PubMed ID: 16649094
    [Abstract] [Full Text] [Related]

  • 15. Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's disease.
    Contin M, Riva R, Martinelli P, Cortelli P, Albani F, Baruzzi A.
    Clin Neuropharmacol; 1999 Sep 24; 22(6):351-5. PubMed ID: 10626097
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease.
    Simon N, Gantcheva R, Bruguerolle B, Viallet F.
    Parkinsonism Relat Disord; 2004 Mar 24; 10(3):137-42. PubMed ID: 15036167
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D, Friedman A.
    Mov Disord; 2007 May 15; 22(7):1033-6. PubMed ID: 17370308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.